Clinical Trial Update: Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia [NA]

View source ↗

Summary

Trial assessing MRI sialography to spare parotid ducts for reduced xerostomia in oropharyngeal/head and neck cancer was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oropharyngeal Cancer

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Oropharynx Cancer, Head and Neck Cancer | NA | Status: WITHDRAWN